ArticleFrontiers in immunology2022

mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model.

Chutamath Sittplangkoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.